|Bid||1,465.50 x 0|
|Ask||1,466.00 x 0|
|Day's range||1,455.00 - 1,498.50|
|52-week range||790.00 - 1,608.00|
|Beta (5Y monthly)||0.82|
|PE ratio (TTM)||22.05|
|Forward dividend & yield||0.35 (2.30%)|
|Ex-dividend date||22 Oct 2020|
|1y target est||N/A|
Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has been awarded a contract to deliver 26 X-ray inspection systems for the Phoenix Suns Arena. The inspection systems will be used to screen deliveries as well as personal belongings of all those entering the arena.
Smiths Detection, a global leader in threat detection and security screening technologies, today reports that its BioFlash® Biological Identifier is capable of detecting SARS-CoV-2 in the air following tests conducted by the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).
Smiths Detection, a global leader in threat detection and security screening technologies, was granted an AOAC INTERNATIONAL Performance Test MethodSM (PTM) program certification number 122005 for its Listeria CANARY® assay. The assay, used in the company’s Zephyr pathogen identifier, gives food and beverage companies a new, rapid solution to screen and protect against dangerous pathogens that are a common contaminate of concern in food-processing environments.